These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12421524)

  • 1. [Severe non-infectious secondary effects of blood transfusion].
    Lozano Molero M
    Med Clin (Barc); 2002 Oct; 119(14):550-4. PubMed ID: 12421524
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood transfusions and graft-vs-host disease.
    Ray TL
    Arch Dermatol; 1990 Oct; 126(10):1347-50. PubMed ID: 2221941
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the complement fixation reaction for preventing the homologous blood syndrome].
    Sumbatov LA; Iunovidova LI
    Grudn Khir; 1988; (4):42-4. PubMed ID: 3181799
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transfusion: risks and future prospects].
    Molaro GL
    G Clin Med; 1990 Oct; 71(10):547-59. PubMed ID: 2289650
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood transfusion and transplantation].
    Ishikura H; Endo J
    Rinsho Byori; 1991 Jul; Suppl 90():139-50. PubMed ID: 1920850
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks of blood transfusion and their prevention.
    Sandler SG; Yu H; Rassai N
    Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating transfusion tribulations.
    Titus K
    CAP Today; 1997 Sep; 11(9):1, 58-60, 62 passim. PubMed ID: 10174335
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
    Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
    J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current risks in blood transfusion in Japan.
    Otsubo H; Yamaguchi K
    Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-transfusion graft vs host disease and its prevention].
    Stanković B
    Vojnosanit Pregl; 2000; 57(2):197-204. PubMed ID: 10934933
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion-associated graft-versus-host disease].
    Chen Z
    Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):291-2. PubMed ID: 10374266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfusion-associated graft-versus-host disease and its prevention].
    Israeli S; Zaizov R
    Harefuah; 1990 Aug; 119(3-4):86-9. PubMed ID: 2227676
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft-v-host disease following blood transfusions.
    Weiden P
    Arch Intern Med; 1984 Aug; 144(8):1557-8. PubMed ID: 6466011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfusion associated graft versus host disease].
    Takahashi K; Juji T
    Rinsho Byori; 1991 Mar; Suppl 88():148-55. PubMed ID: 1856965
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-associated graft-versus-host disease.
    Anderson KC; Weinstein HJ
    N Engl J Med; 1990 Aug; 323(5):315-21. PubMed ID: 2248640
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of TAGVHD warnings in patients receiving purine analogue chemotherapy.
    Cutler FJ; Niciu C; Murphy JA; Soutar RL
    Transfus Med; 2008 Apr; 18(2):137-8. PubMed ID: 18399848
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion associated graft versus host disease (TA-GVHD)].
    Takahashi K
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):605-8. PubMed ID: 9851229
    [No Abstract]   [Full Text] [Related]  

  • 20. [Derivative advantages of autologous blood transfusion].
    Shinmyozu K
    Nihon Seikeigeka Gakkai Zasshi; 1997 Oct; 71(10):535-40. PubMed ID: 9394358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.